Land: Storbritannien
Språk: engelska
Källa: MHRA (Medicines & Healthcare Products Regulatory Agency)
Bisoprolol fumarate
Phoenix Healthcare Distribution Ltd
C07AB07
Bisoprolol fumarate
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02040000
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT BISOPROLOL 5 MG AND 10 MG TABLETS Bisoprolol fumarate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. WHAT BISOPROLOL TABLETS ARE AND WHAT THEY ARE USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BISOPROLOL TABLETS 3. HOW TO TAKE BISOPROLOL TABLETS 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE BISOPROLOL TABLETS 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT BISOPROLOL TABLETS ARE AND WHAT THEY ARE USED FOR Bisoprolol fumarate belongs to a group of medicines called beta-blockers. It is used to treat: - high blood pressure - angina pectoris (pain in the chest caused by blockages in the arteries leading to the heart). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BISOPROLOL TABLETS DO NOT TAKE BISOPROLOL TABLETS - if you are ALLERGIC to Bisoprolol tablets or any of the other ingredients of this medicine (listed in section 6) - if you suffer from SEVERE ASTHMA or from other SEVERE breathing difficulties - if you have acute HEART FAILURE or are in shock caused by heart problems - if you suffer with HEART CONDUCTION or RHYTHM PROBLEMS (2nd or 3rd degree AV-block, sick sinus syndrome or sinoatrial block) - if you have a SLOW HEART RATE of less than 60 beats per minute before starting treatment. - if you have LOW BLOOD PRESSURE - if you suffer from severely BLOCKED BLOOD VESSELS , including BLOOD CIRCULATION PROBLEMS (which may cause your fingers and toes to tingle or turn pale or blue) - if you suffer from INCREASED ACIDITY OF THE BLOOD (metabol Läs hela dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Bisoprolol Fumarate 10mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10mg of the active ingredient bisoprolol fumarate. For excipients, see 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet White, round tablets engraved with ‘Bisoprolol 10’ on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of hypertension. Treatment of angina pectoris. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults:_ The usual dose is 10mg once daily with a maximum recommended dose of 20mg per day. In some patients 5mg per day may be adequate. In patients with final stage impairment of renal function (creatinine clearance <20ml/min) or liver function, the dose should not exceed 10mg bisoprolol once daily. Experience of the use of bisoprolol in renal dialysis patients is limited, however, there is no evidence that the dosage regimen needs to be altered. _Elderly: _ No dosage adjustment is normally required but 5mg per day may be adequate in some patients; as for other adults, dosage may have to be reduced in cases of severe renal or hepatic dysfunction. _ _ _Children: _ There is no paediatric experience with bisoprolol, therefore its use cannot be recommended for children. _Method of administration:_ For oral administration. 4.3 CONTRAINDICATIONS Patients with: • uncontrolled cardiac failure. • cardiogenic shock. • sinoatrial block. • second or third degree AV block. • marked bradycardia (heart rate less than 50 beats/min). • extreme hypotension. • Sick sinus syndrome • Prinzmetal’s (variant) angina. • severe peripheral vascular disease (Raynaud’s disease or syndrome, intermittent claudication). • use of anaesthetics which depress the myocardial activity (e.g. cyclopropane and trichlorethylene). • untreated phaeochromocytoma. • a history of bronchospasm, bronchial asthma or chronic obstructive airways disease. • metabolic acidosis (eg in some diabetics). • after prolonged fasting. • hypersensit Läs hela dokumentet